2026 Outpatient Mental Health Services M&A Market Update

The mental health space continues to attract institutional capital primarily driven by significant unmet demand and a fragmented provider landscape. Constrained provider availability and persistent access gaps create opportunities for practices that can recruit and retain clinicians across therapy and medication management services. The recurring nature of the patient base and a multitude of ancillary services to draw on further supports the investment thesis in the space. These dynamics position well-capitalized practices to gain market share and scale, prompting many owners to explore aligning with a capital or strategic partner to accelerate growth. 

While the segment remains highly attractive to healthcare investors, the buyer landscape has matured, with investors taking a more disciplined approach to evaluating growth, operational performance and earnings sustainability. Buyers are increasingly seeking practices with the infrastructure, volume, management depth, technology, payer relationships, and geographic density required to scale in today’s environment. As such, for founders who have built sizable outpatient practices, 2026 may represent an attractive window to evaluate strategic alternatives, whether that be taking on investment from a capital partner or a strategic partnership with a private equity-backed platform.  

The US mental health market has now reached an estimated $89–95 billion TAM through 2025, and is projected to reach approximately $165–$170 billion by 2034.¹ The sector continues to grow at an attractive compounded annual growth rate of 7.7% through 2026, making it one of the most attractive growth verticals within healthcare services. ² Among adults in the US, 20.6% of the population experienced a form of mental illness in the prior year ³ and nearly half of those who experienced mental illness did not receive treatment.

Outpatient mental health providers play a critical role in the care continuum, offering services ranging from psychotherapy, psychiatric evaluation and medication management to interventional psychiatry, diagnostic assessments, partial hospitalization and intensive outpatient programs. This breadth of services creates opportunities for investors to expand access, build integrated care platforms and support growth across multiple levels of care.

Hybrid delivery has quickly grown into a defining component of care in outpatient mental health as well. Although fully virtual care delivery models have proven clinically effective, and telepsychiatry is the fastest-growing application in mental health, over 60% of patients still want an in-person component ⁴, which has led to models that combine brick and mortar with telehealth. The virtual delivery care model allows for more scalability, while physical clinics strengthen referral relationships and accommodate patients that prefer in-person care. Payors have continued to support virtual care delivery following the pandemic. Since January 2024, Medicare has reimbursed covered telehealth visits delivered to patients in their homes at the physician fee schedule’s non-facility rate, supporting payment comparable to office-based care.

For independent infusion operators and physician practices, demand for infusion has been very strong, but the economics are getting harder to manage alone. Drug margin is the profit engine of an infusion business, and protecting it requires purchasing scale, strong payor contracts and the ability to absorb drug pricing changes. Buyers have noted to PGP that some physician groups have reconsidered their in-office infusion programs as working capital requirements and administrative demands have increased. A private equity or strategic partner can help address these pressures by pooling drug purchasing across sites, strengthening payor contracts and billing, and providing the capital to open new centers.

Valuations for outpatient mental health platforms are driven by several operational and market dependent factors, including scale, service mix, and a strong history of growth. Larger platforms with built out infrastructure and attractive unit economics typically yield higher valuations than single clinic operations.  

Across mental health care models, valuation multiples can vary significantly based on acuity, service mix, scalability, and strategic fit. Higher-acuity or more differentiated models, such as interventional psychiatry and Partial Hospitalization (PHP) and Intensive Outpatient (IOP) programs, can reach the low double-digit range for scaled assets, while traditional outpatient psychotherapy practices that lack medication management or specialty psychiatry services may command lower multiples. At the same time, many strategic and financial buyers are increasingly seeking vertically integrated platforms that span multiple levels of care and modalities, creating opportunities for differentiated assets to command premium valuations when they align with a buyer’s broader growth strategy.  

Based on PGP’s transaction experience advising more than half a dozen clients across the outpatient mental health and psychiatry sectors, practices that can demonstrate the following characteristics are best positioned to achieve the most attractive and highest-value outcomes: 

• Repeatable Growth Plan – Defined, repeatable growth strategy with a clear roadmap to market leading growth 

• Robust Tech Enablement – Platforms leveraging IT infrastructure for RCM, clinical documentation, and predictive analytics achieve meaningfully better operational performance and command premium valuations 

• Multi-state Scalability – Fragmented competitive landscape creates a clear path to de novo and acquisition-driven geographic expansion 

• Quality Outcomes – Demonstrated ability to provide quality care and track optimal patient outcomes 

• Payor Mix and Compliance – Diversified commercial and government payor relationships, alongside strong clinical compliance and accreditation, are key indicators of program durability 

The buyer universe has expanded significantly in recent years as private equity firms, strategic healthcare acquirors, public companies, and technology-enabled platforms are all pursuing opportunities across the full continuum of mental health services. This broad buyer base creates competition for assets and a supply and demand imbalance that favors sellers. 

Operators have taken advantage of the situation as mental health M&A activity surged 42% in 2025, characterized by both add-on acquisition activity as well as new private equity investment. ⁵ The landmark transaction which was recently consummated was Universal Health Services’ acquisition of Talkspace for $835 million. Talkspace will help UHS diversify into lower-cost delivery services, expand its commercial payor base, create a referral flywheel, and provide a scalable clinician workforce. Given how distinctly different the two organizations are operationally, it will be interesting to see how management integrates the two businesses to execute on the thesis. 

The buyer universe will continue to diversify with transactions coming from both financial as well as a diverse mix of strategic acquirors, spanning pure-play outpatient providers to large systems seeking to capture downstream care and build integrated mental health networks. 

The competitive environment continues to evolve as participants seek to build integrated, multi-state mental health platforms. Overall mental health M&A approached pre-pandemic-era peak deal levels in 2025, with outpatient counseling and psychiatric care as the primary drivers of this surge. 

Below is a list of some of the more active outpatient behavioral health platforms: 

Strong sector tailwinds have fueled significant transaction activity, with private equity firms investing in the space and strategic buyers pursuing acquisitions to expand their geographic reach and build market density. As the most active advisor in the sector, PGP has played a leading role in outpatient mental health transaction activity.

PGP has advised on a number of outpatient mental health transactions over the years, making it one of the most active transaction advisors in the industry. Select highlighted transactions include: 

• September 2022: PGP advised The Ross Center (“TRC”) in its Partnership with ARC Health (Thurston Group). TRC is the leader in psychiatric and psychological care in Washington, Northern Virginia, and New York, with more than 50 board-certified clinicians. The transaction represents ARC’s expansion into the Washington, DC-area and greater Mid-Atlantic markets. 

• May 2023: PGP advised Silver Lake Psychology in its multi-state partnership with ARC Health (Thurston Group). Silver Lake’s more than 400 providers offer a range of counseling services from offices in California, Colorado, Tennessee, and Washington, DC. 

• January 2025: PGP advised GBCC Behavioral Health (“GBCC”) in its partnership with Orchard Mental Health Group (Graham Group). GBCC has 75+ providers and 6 clinic locations serving the greater Baltimore, MD area.

The highly fragmented nature of the mental health market creates a compelling opportunity for well-run regional platforms to command premium valuations from strategic and financial buyers seeking to build immediate scale. For acquirers, partnering with established practices can accelerate market entry, create geographic density, and generate meaningful operating synergies—particularly as technology and AI enable greater efficiency across administrative and back-office functions. 

For owners, partnering with a larger organization can provide access to institutional resources while reducing the administrative complexity of remaining independent. Scaled platforms can centralize functions such as revenue cycle management, compliance, finance, human resources, and other administrative operations, allowing clinical leadership to focus more of its time and resources on patient care, provider recruitment, and continued growth. At the same time, institutional infrastructure can help owners navigate an increasingly complex regulatory and reimbursement environment while providing the capital and operational capabilities needed to expand into new markets. 

PGP continues to see growing interest from practice owners and operators exploring potential transactions for a variety of reasons, including: 

• Peak Valuation Environment. Unlike some of the other subsectors in healthcare services, the buyer universe for mental health assets continues to be competitive, with private equity sponsors and strategic aggregators all actively pursuing acquisitions.  

• Regulatory Uncertainty. The pending outcome of mental health parity enforcement and Medicaid policy shifts creates material binary risk for independent operators.  

• Operational Complexity. The cost and complexity of remaining independent continues to rise as programs face increasing demands around RCM, AI integration, payor contracting, and multi-state licensure and compliance requirements. 

• Potential Liquidity Events. Many established platforms within the mental health space are approaching the tail end of their investment cycle, with several secondary buyouts expected to occur in the near term. Platforms nearing an exit have historically been more aggressive in their M&A strategy. 

• Private Equity Dry Powder Remains at Record Levels. Sponsors are entering 2026 with high amounts of uncommitted capital and a mandate to deploy in high-growth mental health verticals, intensifying competition for quality assets. 

Overall, the market continues to be favorable for high-quality assets, as buyer demand remains concentrated around platforms that demonstrate growth, clinical outcomes, infrastructure, and scalability. With strategic acquirers, private equity-backed platforms, health systems, and other institutional buyers competing for a limited supply of scaled assets, outpatient mental health businesses with these characteristics can attract significant interest from the market. Given the proliferation of mental health platforms in recent years, success has varied across organizations, underscoring the importance of identifying potential partners with a demonstrated track record and strong cultural alignment. 

For founder-owned and independently operated platforms, now may be an opportune time to evaluate strategic alternatives from a position of strength and in a favorable market.